日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-Alpha

抗体靶向干扰素-α增强抗 CD19 嵌合抗原受体 T 细胞对抗 B 细胞淋巴瘤的活性

Patricia A Young, Reiko E Yamada, Kham R Trinh, Alex Vasuthasawat, Satiro De Oliveira, Douglas H Yamada, Sherie L Morrison, John M Timmerman

Targeted immunotherapy using anti-CD138-interferon α fusion proteins and bortezomib results in synergistic protection against multiple myeloma

使用抗 CD138-干扰素 α 融合蛋白和硼替佐米进行靶向免疫治疗可产生针对多发性骨髓瘤的协同保护作用

Alex Vasuthasawat, Esther M Yoo, Kham R Trinh, Alan Lichtenstein, John M Timmerman, Sherie L Morrison

Anti-CD20-interferon-β fusion protein therapy of murine B-cell lymphomas

抗CD20-干扰素-β融合蛋白疗法治疗小鼠B细胞淋巴瘤

Trinh, Kham R; Vasuthasawat, Alex; Steward, Kristopher K; Yamada, Reiko E; Timmerman, John M; Morrison, Sherie L